https://patentbrief.org/company/gilead-sciences-inc Plain-English explanations of patents assigned to Gilead Sciences Inc, newest first. en-us Mon, 15 Jun 2026 05:56:13 GMT https://patentbrief.org/patent/us/9744181/harvoni-ledipasvir-sofosbuvir A patent detailing a stable, fixed-dose combination of two HIV drugs, tenofovir disoproxil fumarate and emtricitabine, designed to prevent chemical breakdown in a single tablet. Tue, 29 Aug 2017 00:00:00 GMT https://patentbrief.org/patent/us/9744181/harvoni-ledipasvir-sofosbuvir https://patentbrief.org/patent/us/9216996/genvoya-elvitegravir-cobicistat-taf-ftc This patent covers specific chemical structures designed to block HIV from replicating in human cells, providing a foundation for new antiviral medications. Tue, 22 Dec 2015 00:00:00 GMT https://patentbrief.org/patent/us/9216996/genvoya-elvitegravir-cobicistat-taf-ftc https://patentbrief.org/patent/us/8592397/truvada-tdf-ftc-for-prep This patent describes a stable, single-pill combination of two HIV drugs, tenofovir disoproxil fumarate and emtricitabine, designed to prevent them from breaking down when stored together. Tue, 26 Nov 2013 00:00:00 GMT https://patentbrief.org/patent/us/8592397/truvada-tdf-ftc-for-prep